Should I buy Monster Beverage (MNST) stock or is it too late?
⭐ The most reliable of them, either direction: Stifel — 73% of its targets hit on this sector (197 calls tested). It aims for $52.50 (+21 %), call made on July 17, 2026, maturing on July 17, 2027 (89 d ago).
Firm-by-firm track record on Monster Beverage
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| RBC Capital | 75 % | +33.3 % | 12 | $50 +15% |
| Stifel | 80 % | +24.9 % | 25 | $53 +21% |
| Deutsche Bank | 86 % | +23.3 % | 14 | $49 +13% |
| Wells Fargo | 89 % | +22.8 % | 19 | $48 +11% |
| JP Morgan | 83 % | +21.0 % | 6 | $42 -4% |
| BMO Capital | 71 % | +17.8 % | 7 | $48 +10% |
| Morgan Stanley | 76 % | +17.2 % | 25 | $52 +19% |
| Citigroup | 75 % | +16.5 % | 20 | $57 +30% |
✅ Reasons to believe
- 62% of analysts rate it a buy (Buy consensus, 13 ratings) — a sign of market conviction.
- Median price target $50, i.e. +15% from the current price ($43).
- The most reliable firm on MNST, Wells Fargo (89% hit rate, 19 scored calls), targets $48 (call made on October 5, 2026, maturing on October 5, 2027) (+11%) in its most recent call, and $38 (call made on November 7, 2025, maturing on November 7, 2026) (-13%) in the one coming due soonest.
⚠️ Reasons to hesitate
- The consensus is not unanimous: of 13 ratings, 5 are neutral.
- High valuation (P/E ~40): strong growth is already "priced in", leaving little room for error.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
- No dividend: your return depends only on price appreciation.
The analyst consensus on MNST
Median target $50 (+15%) · 13 ratings · Buy consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Monster Beverage now?
We won't decide for you. The facts: 62% of analysts rate it a buy, median target $50 (+15%), and Wells Fargo (most reliable on MNST, 89%) targets $48. Weigh that against valuation (P/E ~40). This is not personalized advice.
Is it too late to invest in Monster Beverage?
Not according to analysts: the median target ($50) is still +15% above the current price ($43) (most reliable on MNST: Wells Fargo, 89%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Monster Beverage still worth investing in?
It depends on the gap between the price ($43) and its estimated value: analysts target $50 on median (+15%), with 62% buys (most reliable on MNST: Wells Fargo, 89%). Cross-check with their real reliability on MNST and the cautions above. Information, not advice.
What's the main risk in buying MNST?
The consensus is not unanimous: of 13 ratings, 5 are neutral.
→ Go deeper: the full Monster Beverage profile (consensus, analyst reliability, price target, performance).